French Athletics Stakeholders' Perceptions of Relevance and Expectations on Injury Prevention.


Journal

International journal of sports medicine
ISSN: 1439-3964
Titre abrégé: Int J Sports Med
Pays: Germany
ID NLM: 8008349

Informations de publication

Date de publication:
Nov 2022
Historique:
pubmed: 5 5 2022
medline: 3 11 2022
entrez: 4 5 2022
Statut: ppublish

Résumé

This study aimed to explore how stakeholders in athletics perceive the relevance of injury prevention, determine their communication preferences, and describe their expectations regarding injury prevention. We conducted a cross-sectional study using an exploratory online survey with high-level athletes (i. e. listed by the French ministry of sports), non-high-level athletes (i. e. all competitive level except high-level athletes), coaches, and health professionals licensed with the French Federation of Athletics. The survey was composed of three parts regarding stakeholder's characteristics (4 questions), perceived relevance (2 questions), communication preferences and expectations (3 questions) towards injury prevention. There were 2,864 responders to the survey. Almost all responders found that injury prevention is relevant (97.7% [95% CI 97.0% to 98.2%]), without any significant differences in the distribution between stakeholders' age, experience and sex (

Identifiants

pubmed: 35508199
doi: 10.1055/a-1843-6533
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1052-1060

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare that they have no conflict of interest.

Auteurs

Pascal Edouard (P)

Univ Lyon, UJM-Saint-Etienne, Inter-university Laboratory of Human Movement Biology, EA 7424, F-42023, Saint-Etienne, France.
Department of Clinical and Exercise Physiology, Sports Medicine Unit, University Hospital of Saint-Etienne, Faculty of Medicine, Saint-Etienne, France.
European Athletics Medical & Anti Doping Commission, European Athletics Association (EAA), Lausanne, Switzerland.

Alexis Ruffault (A)

French Institute of Sport (INSEP), Laboratory Sport, Expertise and Performance (EA 7370), Paris, France.
Unité de Recherche interfacultaire Santé et Société (URiSS), Université de Liège, Liège, Belgium.

Caroline Bolling (C)

Amsterdam Collaboration on Health & Safety in Sports (ACHSS), Department of Public and Occupational Health, Amsterdam UMC, VU University, Amsterdam Movement Sciences, Amsterdam, The Netherlands.

Laurent Navarro (L)

Mines Saint-Etienne, Univ Lyon, Univ Jean Monnet, INSERM, U 1059 Sainbiose, Centre CIS, F-42023 Saint-Etienne France.

Simon Martin (S)

Laboratoire Adaptations Physiologiques à l'Exercice et Réadaptation à l'Effort (APERE), Université Picardie Jules Verne, Amiens, France.
Center of Research on Welfare Health and Sport, Halmstad University, Halmstad, Sweden.

Frédéric Depiesse (F)

Clinalliance Villiers sur Orge et Institut Mutualiste de Montsouris, Paris, France.

Rasmus Oestergaard Nielsen (R)

Department of Public Health, Aarhus University, Denmark.
Research Unit for General Practice, Aarhus, Denmark.

Evert Verhagen (E)

Amsterdam Collaboration on Health & Safety in Sports (ACHSS), Department of Public and Occupational Health, Amsterdam UMC, VU University, Amsterdam Movement Sciences, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH